Fritsché R, Pahud J J, Pecquet S, Pfeifer A
Nestec Ltd. Research Center, Vers-chez-les-Blanc, Lausanne, Switzerland.
J Allergy Clin Immunol. 1997 Aug;100(2):266-73. doi: 10.1016/s0091-6749(97)70235-5.
Oral administration of an antigen has been shown to suppress the specific immune response to this antigen. This approach, called oral tolerance, has been demonstrated with intact proteins in animal models for prevention of allergy and autoimmune diseases.
The purpose of this study was to determine whether oral tolerance can be induced with protein peptides. Partially hydrolyzed and extensively hydrolyzed cow's milk formulas were compared for their capacity to induce tolerance to cow's milk proteins.
Five-week-old Sprague-Dawley rats were fed cow's milk formulas ad libitum from day 1 to day 19. All animals were immunized with beta-lactoglobulin and ovalbumin on day 5 and bled on day 19. Sera were analyzed for specific IgE and IgG antibodies by ELISA and for functional IgE response by in vitro mast cell mediator (tritiated serotonin) release. In vivo modulation of intestinal mast cells was analyzed by the specific release of the rat mast cell protease II, and T-cell response was determined by tritiated thymidine incorporation into lymph node lymphocytes.
Oral administration of a partially hydrolyzed cow's milk formula suppresses specific serum IgE and IgG anti-beta-lactoglobulin antibodies, as well as mediator release from rat mast cells and T-lymphocyte response. This suppression was shown to be antigen-specific and dose-dependent. An extensively hydrolyzed formula was unable to achieve the induction of such an oral tolerance.
These results support the view that partially hydrolyzed proteins are able to induce specific oral tolerance, whereas extensively hydrolyzed proteins are not.
口服抗原已被证明可抑制对该抗原的特异性免疫反应。这种方法称为口服耐受,已在动物模型中用完整蛋白质证明可预防过敏和自身免疫性疾病。
本研究的目的是确定蛋白肽是否能诱导口服耐受。比较部分水解和深度水解的牛奶配方对诱导牛奶蛋白耐受的能力。
5周龄的斯普拉格-道利大鼠从第1天至第19天随意喂食牛奶配方。所有动物在第5天用β-乳球蛋白和卵清蛋白免疫,并在第19天采血。通过ELISA分析血清中的特异性IgE和IgG抗体,并通过体外肥大细胞介质(氚标记的血清素)释放分析功能性IgE反应。通过大鼠肥大细胞蛋白酶II的特异性释放分析肠道肥大细胞的体内调节,并通过将氚标记的胸腺嘧啶核苷掺入淋巴结淋巴细胞来确定T细胞反应。
口服部分水解的牛奶配方可抑制特异性血清IgE和IgG抗β-乳球蛋白抗体,以及大鼠肥大细胞介质释放和T淋巴细胞反应。这种抑制被证明是抗原特异性和剂量依赖性的。深度水解配方无法诱导这种口服耐受。
这些结果支持以下观点,即部分水解蛋白能够诱导特异性口服耐受,而深度水解蛋白则不能。